The Food and Drug Administration notified Centurion the product could be contaminated with Burkholderia cepacia bacteria. The FDA believes the cold medicine may have been manufactured in a PharmaTech facility linked to products contaminated by the bacteria. Numerous drug distributors have issued recalls in the last month relating to drugs manufactured by PharmaTech.
Centurion Labs is notifying customers in 14 states about the recall. The company has not found B. cepacia in the recalled product or received any customer complaints regarding medicine.
More articles on supply chain:
US Bioservices to pay $13.4M to resolve kickback suit
Patients brace for price of ‘breakthrough’ leukemia drug CTL019
Price of first FDA-approved ALS treatment in 20 years limits patient access at VCU Medical Center
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
